Loading...
Metabolic & Weight Management
Liraglutide
Liraglutide is a GLP-1 receptor agonist with 97% homology to native human GLP-1. It supports weight management by regulating appetite and caloric intake, and has been widely studied for its metabolic and cardiovascular benefits.
Available Delivery Methods
SubQ Injection
Why Liraglutide
Key Benefits
- Supports clinically meaningful weight loss
- Regulates appetite and reduces caloric intake
- Improves glycemic control and metabolic markers
- Well-established safety and efficacy profile
- Daily dosing allows for precise titration
The Science
How It Works
Liraglutide binds to and activates the GLP-1 receptor, stimulating glucose-dependent insulin secretion, suppressing inappropriate glucagon release, slowing gastric emptying, and reducing appetite via hypothalamic signaling pathways.
Safety & Side Effects
Gastrointestinal side effects (nausea, constipation, diarrhea) are most common during initial dose escalation and generally improve over time. Contraindicated in patients with a personal or family history of medullary thyroid carcinoma.
Metabolic & Weight Management
Related Therapies
Interested in Liraglutide?
Speak with a licensed clinician to find out if Liraglutide is right for your protocol.
Book a Consultation